Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://www.ncbi.nlm.nih.gov/pubmed/25830125
http://dx.doi.org/10.5045/br.2015.50.1.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://www.ncbi.nlm.nih.gov/pubmed/25830125
http://dx.doi.org/10.5045/br.2015.50.1.7

Ejemplares similares